No End in Sight, Bladder Cancer Drug Shortage Takes a Toll No End in Sight, Bladder Cancer Drug Shortage Takes a Toll
The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Eyes | Health | Hematology | Immunotherapy | Urology & Nephrology | USA Health